Axa S.A. Has $102.08 Million Stake in Oracle Corporation $ORCL

Axa S.A. lifted its stake in shares of Oracle Corporation (NYSE:ORCL) by 52.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 466,887 shares of the enterprise software provider’s stock after purchasing an additional 160,638 shares during the period. Axa S.A.’s holdings in Oracle were worth $102,076,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of ORCL. Snider Financial Group increased its position in Oracle by 1.3% in the second quarter. Snider Financial Group now owns 3,204 shares of the enterprise software provider’s stock worth $701,000 after purchasing an additional 40 shares during the period. SNS Financial Group LLC boosted its stake in shares of Oracle by 0.9% in the 2nd quarter. SNS Financial Group LLC now owns 4,896 shares of the enterprise software provider’s stock valued at $1,070,000 after purchasing an additional 42 shares during the last quarter. PKS Advisory Services LLC boosted its stake in shares of Oracle by 1.9% in the 2nd quarter. PKS Advisory Services LLC now owns 2,211 shares of the enterprise software provider’s stock valued at $483,000 after purchasing an additional 42 shares during the last quarter. Reyes Financial Architecture Inc. grew its position in shares of Oracle by 7.2% during the 2nd quarter. Reyes Financial Architecture Inc. now owns 643 shares of the enterprise software provider’s stock worth $141,000 after buying an additional 43 shares during the period. Finally, Creative Capital Management Investments LLC raised its stake in shares of Oracle by 5.7% during the second quarter. Creative Capital Management Investments LLC now owns 798 shares of the enterprise software provider’s stock worth $174,000 after buying an additional 43 shares during the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Royal Bank Of Canada restated a “sector perform” rating and set a $310.00 target price on shares of Oracle in a research report on Friday. Rothschild Redb upgraded shares of Oracle to a “strong sell” rating in a report on Thursday, September 25th. Evercore ISI increased their target price on shares of Oracle from $350.00 to $385.00 and gave the stock an “outperform” rating in a report on Friday, October 17th. Weiss Ratings reissued a “hold (c+)” rating on shares of Oracle in a report on Monday, December 1st. Finally, Piper Sandler upped their price objective on shares of Oracle from $330.00 to $380.00 and gave the company an “overweight” rating in a research report on Friday, October 17th. Four research analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Oracle presently has an average rating of “Moderate Buy” and an average price target of $320.84.

Insider Transactions at Oracle

In related news, EVP Stuart Levey sold 19,758 shares of the business’s stock in a transaction on Friday, October 10th. The shares were sold at an average price of $300.00, for a total value of $5,927,400.00. Following the transaction, the executive vice president owned 18,429 shares in the company, valued at $5,528,700. The trade was a 51.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jeffrey Berg sold 49,365 shares of Oracle stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $283.02, for a total value of $13,971,282.30. Following the completion of the sale, the director owned 151,999 shares of the company’s stock, valued at approximately $43,018,756.98. The trade was a 24.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 204,254 shares of company stock worth $60,227,807. Company insiders own 40.90% of the company’s stock.

Oracle Price Performance

Shares of ORCL stock opened at $220.53 on Tuesday. The business has a fifty day simple moving average of $251.84 and a 200 day simple moving average of $240.56. The company has a market cap of $628.67 billion, a P/E ratio of 51.05, a P/E/G ratio of 2.47 and a beta of 1.66. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $345.72.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business had revenue of $14.93 billion during the quarter, compared to the consensus estimate of $15.04 billion. During the same quarter last year, the business earned $1.39 EPS. The firm’s quarterly revenue was up 12.2% compared to the same quarter last year. On average, sell-side analysts forecast that Oracle Corporation will post 5 EPS for the current fiscal year.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.